AI for Drug Discovery

Using artificial intelligence to help accelerate drug discovery, screening, development, and related pharmaceutical research.

Lux logo LUX TAKE:

After many years of development and interest, major pharmaceutical companies are making more significant investments in AI and forging more and deeper relationships with startups. The innovations coming out of these processes are being augmented and finding their way into the innovation processes of other physical industries.

Related companies Schrödinger, Deep Genomics, InsideDNA, ResultCare, Cloud Pharmaceuticals, Numerate, Atomwise, Nimbus Therapeutics, Deep 6 AI, Desktop Genetics, Recursion Pharmaceuticals , Berg, Insilico Medicine, XtalPi, NuMedii, OWKIN, twoXAR, Cyclica, BioXcel Therapeutics, Verge Genomics, Exscientia, Globavir Biosciences, Engine Biosciences, Healx, Lantern Pharma, Standigm, Bioage Labs, e-Therapeutics, GTN, Mind the Byte, Quantitative Medicine, Linguamatics, BenevolentAI, Cyrus Biotechnology, Zymol

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978